Patent Application
20150329881
This application claims the benefit of Korean Patent Application No. 10-2014-0057954, filed on May 14, 2014, in the Korean Intellectual Property Office, the entire disclosure of which is hereby incorporated by reference.
Incorporated by reference in its entirety herein is a computer-readable nucleotide/amino acid sequence listing submitted herewith and identified as follows: One 510,691 bytes ASCII (Text) file named “719112_ST25.TXT” created Feb. 3, 2015.
1. Field
The present disclosure relates to microorganisms having a novel acrylic acid synthesis pathway and a method of producing an acrylic acid by using the microorganisms.
2. Description of the Related Art
Recently, due to the rapid increase in the price of petroleum and as pressure to decrease carbon emissions has become a global issue, efforts to produce fuel or chemicals through a carbon-neutral biological process instead of a conventional chemical process using petroleum as a raw material have continued.
An acrylic acid is a bulk chemical that has a market value of about 10 trillion Korean Won (KRW). The recent demand for an environment-friendly production method has increased the need for a method of producing an acrylic acid through a pathway other than a petroleum-based pathway.
An example of a non-petroleum-based acrylic acid production pathway may be a method including producing 3-hydroxypropionic acid (3-HP) from glycerol or glucose; and chemically isolating and purifying the 3-HP. However, this method includes isolating the produced 3-HP from a culture, purifying the 3-HP, and chemically converting the 3-HP by using a catalyst. Therefore, the cost of the isolation, purification, and conversion is added to the 3-HP production cost, and thus the method may not be competitive with respect to a method of producing an acrylic acid derived from a petroleum-based compound.
Even in the conventional method, alternative microorganisms capable of producing acrylic acid and a method of producing an acrylic acid by using the microorganisms are needed.
Provided is a genetically engineered microorganism that produces acrylate, wherein the genetically engineered microorganism comprises a genetic modification that increases activities of a CoA transferase catalyzing conversion of 3-hydroxypropionic acid (3-HP) to 3-hydroxypropionyl-CoA (3-HP-CoA), a 3-HP-CoA dehydratase catalyzing conversion of the 3-HP-CoA to acrylyl-CoA, and an enzyme catalyzing the acrylyl-CoA to an acrylate in the microorganisms are increased, compared to cells that are not genetically engineered. Also provided is a method of preparing the engineered microorganism by introducing into a microorganism an exogenous polynucleotide encoding the CoA transferase, an exogenous polynucleotide encoding 3-HP-CoA dehydratase, and an exogenous polynucleotide encoding an enzyme catalyzing conversion of acrylyl-CoA to acrylate.
Further provided is a method of producing an acrylate, wherein the method includes culturing the engineered microorganism in a culture medium. The acrylate produced by the microorganism can be recovered from the culture.
Additional aspects will be set forth in part in the description which follows and, in part, will be apparent from the description, or may be learned by practice of the presented embodiments.
These and/or other aspects will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings in which:
Reference will now be made in detail to embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to like elements throughout. In this regard, the present embodiments may have different forms and should not be construed as being limited to the descriptions set forth herein. Accordingly, the embodiments are merely described below, by referring to the figures, to explain aspects of the present description.
As used herein, the wording “increase in activity” or “increased activity” and the like in reference to a cell, an enzyme, a polypeptide, or a protein may refer to any detectable increase in activity sufficient to show that the activity level of the cell, enzyme, polypeptide, or protein is higher than that of a comparable cell, enzyme, polypeptide, or protein (e.g., a cell, polypeptide, protein or enzyme of the same type that is not genetically engineered). For instance, the activity of a cell, an enzyme, a polypeptide, or protein may be increased by about 5% or more, about 10% or more, about 15% or more, about 20% or more, about 30% or more, about 50% or more, about 60% or more, about 70% or more, about 100%, about 200%, or about 300%, compared to the same biochemical activity of an unmanipulated polypeptide, protein, or enzyme, or the polypeptide, protein, or enzyme of an unmanipulated (non-genetically engineered) cell. Increased activity may be identified by using a method known in the art.
The increased activity of a polypeptide, protein, or enzyme may occur, for example, due to increased gene expression or increased specific activity of an enzyme, polypeptide or protein (hereinafter referred to collectively as “polypeptide”). The increased expression may occur by introducing a polynucleotide encoding a polypeptide into a cell, increasing a copy number of the polynucleotide in the cell, or mutating a regulatory region of the polynucleotide. A polynucleotide that is introduced or present in an increased copy number may be an endogenous gene or an exogenous gene. The endogenous gene refers to a gene that exists in a genetic material included in a microorganism prior to genetic manipulation of the microorganism. The exogenous gene refers to a gene that is introduced into a host cell, such as a gene that is integrated into a host cell genome, wherein the introduced gene may be homologous or heterologous with respect to the host cell genome.
The expression “increased copy number” may include an increase in copy number by an introduction of an exogenous gene, or amplification of an endogenous gene. The expression “increased copy number” may also include a copy number increase by genetically manipulating a cell that did not previously have a gene so as to have the gene in the cell. The introduction of the gene may occur by using a vehicle such as a vector. The introduction may be a transient introduction, in which the gene is not integrated into the genome, or an integration into the genome. The introduction may, for example, occur by introducing a vector inserted with a polynucleotide encoding a desired polypeptide into the cell and then replicating the vector in the cell or integrating the polynucleotide into the genome of the cell and then replicating the polynucleotide together with the replication of the genome.
As used herein, the term “genetic modification” may refer to introduction of a polynucleotide encoding a polypeptide (i.e., an increase in copy number of the gene), or substitution, addition, insertion, or deletion of at least one nucleotide with a genetic material of a parent cell, or chemical mutation of a genetic material of a parent cell. In other words, genetic modification may include cases associated with a coding region of a polypeptide or a functional fragment thereof of a polypeptide that is heterologous, homologous, or both heterologous and homologous with a referenced species. Genetic modification may also refer to modification in non-coding regulatory regions that are capable of modifying expression of a gene or an operon, wherein the non-coding regulatory regions include a 5′-non coding sequence and/or a 3′-non coding sequence.
The term “gene” as used herein refers to a nucleic acid fragment expressing a specific protein and may include a regulatory sequence such as a 5′-non-coding sequence and a 3′-non-coding sequence in addition to a coding region. The regulatory region may include a promoter, an enhancer, an operator, a ribosome binding site, a poly(A) binding sequence, and a terminator region.
The term “endogenous” refers to a referenced molecule (e.g., nucleic acid) or activity already present in the host cell prior to a particular genetic modification (e.g., a genetic composition, trait, or biosynthetic activity of a “wild-type” cell or a parent cell).
The term “heterologous” refers to molecule (e.g., nucleic acid) or activity derived from a source other than referenced species; and the term “homologous” refers to a molecule (e.g., nucleic acid) or activity derived from a host parent cell. Accordingly, an exogenous molecule or activity (e.g., expression of an exogenous coding nucleic acid) may be heterologous (e.g., a coding nucleic acid from a different species) or homologous (e.g., an additional copy of a coding nucleic acid from the same species) or both.
The term “secretion” as used herein refers to a movement of a material from a cell interior to a periplasmic space or an extracellular environment.
The terms “cell”, “strain”, or “microorganism” as used herein may be interchangeably used and may include bacteria, yeast, fungi, or the like.
The term “acrylic acid” as used herein may refer to an acrylic acid, an acrylate, or its salt. An acrylic acid may be produced by fermentation or enzyme reaction of microorganisms.
The expression “decreased activity”, “decrease in activity” or “reduced activity” of a cell or polypeptide (including an enzyme or protein) refers to an activity level at which a cell or polypeptide shows no activity or the activity level that is lower than that of a comparable cell of the same type (e.g., a cell that is not genetically engineered) or the original polypeptide. For instance, the activity of a cell or polypeptide may be decreased by about 20% or more, about 30% or more, about 40% or more, about 50% or more, about 55% or more, about 60% or more, about 70% or more, about 75% or more, about 80% or more, about 85% or more, about 90% or more, about 95% or more, or about 100%, compared to the same biochemical activity of an unmanipulated polypeptide or unmanipulated (i.e., not genetically engineered) cells. The decreased activity includes the case in which the enzyme is inactive or has reduced activity even when the enzyme is expressed and the case in which the gene encoding the enzyme is not expressed or has reduced expression in comparison to the unmanipulated gene or the unmanipulated cells, even when the enzyme is expressed.
The reduced activity of enzyme polypeptide (including an enzyme or protein) may be due to deletion or disruption of the gene encoding the polypeptide. The “deletion” or the “disruption” of the gene refers to mutation, substitution, or deletion of a part or entirety of the genes, or a promoter or a terminator region thereof, or an insertion of at least one base to the gene, such that the gene may not be expressed, have reduced expression, or show no activity or reduced activity of the polypeptide, even when the gene is expressed. The deletion or the disruption of the gene may be achieved by genetic manipulation such as homologous recombination, mutagenesis, or molecular evolution. When a cell includes a plurality of the same genes or two or more different paralogs, one or more genes may be removed or disrupted.
A sequence identity of nucleic acid or polypeptide according to an embodiment of the present disclosure refers to the extent of identity between bases or amino acid residues of sequences after aligning the sequences such that they maximally match in certain comparative regions. The sequence identity is a value calculated by optimally aligning two sequences at certain comparative regions, wherein portions of the sequences at the certain comparative regions may be added or deleted, compared to reference sequences. A percentage of sequence identity may be calculated by, for example, comparing two optimally aligned sequences in the entire comparative region, determining the number of locations in which the same amino acids or nucleic acids appear at corresponding positions in each aligned sequence (i.e. matched locations), dividing the number of matched locations by the total number of locations in the comparative region (that is, the size of the range), and multiplying by 100 to calculate the percentage of the sequence identity. The percentage of the sequence identity may be calculated by using a known sequence comparison program, and examples of such program include BLASTN (NCBI), CLC Main Workbench (CLC bio), and MegAlign™ (DNASTAR Inc).
Various levels of sequence identity may be used to identify various types of polypeptides or polynucleotides having the same or similar functions. For example, a sequence identity of about 50% or more, about 55% or more, about 60% or more, about 65% or more, about 70% or more, about 75% or more, about 80% or more, about 85% or more, about 90% or more, about 95% or more, about 96% or more, about 97% or more, about 98% or more, about 99% or more, or 100% may be used.
According to an aspect of the present disclosure, provided is a microorganism capable of producing acrylate, wherein activities of a CoA transferase catalyzing conversion of 3-hydroxypropionic acid (3-HP) to 3-hydroxypropionyl-CoA (3-HP-CoA), a 3-HP-CoA dehydratase catalyzing conversion of the 3-HP-CoA to acrylyl-CoA, and an enzyme catalyzing the acrylyl-CoA to an acrylate in the microorganisms are increased, compared to unengineered cells (i.e., cells that are not genetically engineered).
The CoA transferase may belong to EC 2.8.3.8, EC 3.1.2.-, or EC 6.2.1.17. The CoA transferase may have an activity catalyzing conversion of 3-HP to 3-HP-CoA, wherein the activity is higher than an activity catalyzing a reversed reaction of the conversion. The CoA transferase may include an amino acid sequence having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to at least one amino acid sequence of SEQ ID NOS: 1 to 10. The polynucleotide encoding the CoA transferase may have a nucleotide sequence encoding an amino acid sequence having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to at least one amino acid sequence of SEQ ID NOS: 1 to 10. The polynucleotide encoding the CoA transferase may have a sequence identity of 95% or more to at least one nucleotide sequence of SEQ ID NOS: 11 to 20. The CoA transferase may be at least one selected from enzymes shown in Table 1. All the enzymes of Table 1 may be E1-type.
Clostridium propionicum
Escherichia coli (strain K12)
Cupriavidus necator
Halomonas smyrnensis
Ruegeria pomeroyi DSS-3
Desulfosporosinus youngiae
Peptoniphilus indolicus ATCC
Desulfosporosinus meridiei
Desulfosporosinus orientis
Peptostreptococcus
anaerobius CAG: 621
The 3-HP-CoA dehydratase may belong to EC 4.2.1.- including EC 4.2.1.17, EC 4.2.1.55, and EC 4.2.1.166. The 3-HP-CoA dehydratase may have an activity catalyzing conversion of 3-HP-CoA to acrylyl-CoA, wherein the activity is higher than an activity catalyzing a reversed reaction of the conversion. The 3-HP-CoA dehydratase may include amino acid sequences having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to at least one amino acid sequence of SEQ ID NOS: 21 to 98 and 401. The polynucleotide encoding 3-HP-CoA dehydratase may encode amino acid sequences having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to at least one amino acid sequence of SEQ ID NOS: 21 to 98 and 401. The polynucleotide encoding 3-HP-CoA dehydratase may have a sequence identity of about 95% or more to one or more nucleotide sequence of SEQ ID NOS: 99 to 176 and 402. The 3-HP-CoA dehydratase may be at least one selected from enzymes shown in Tables 2 to 5. The enzymes shown in Tables 2 to 5 may be E2-type. The term “sequence*” as used herein denotes SEQ ID NO. of an amino acid/SEQ ID NO. of a nucleotide.
Dictyostelium
discoideum (Slime
Clostridium
acetobutylicum
Clostridium difficile
pasteurianum
Clostridium
pasteurianum
Megasphaera elsdenii
Metallosphaera sedula
Clostridicum kluyvery
Sulfolobus tokodaii
Geobacter
metallireducens
Sulfolobus solfataricus
Syntrophobacter
fumaroxidans
Porphyromonas
gingivalis
Polynucleobacter
necessarius subsp.
Asymbioticus
Sulfolobus tokodaii
Gordonia terrae C-6
Halalkalicoccus jeotgali
Carboxydothermus
hydrogenoformans
Thermomicrobium
roseum
Methylobacterium
extorquens
Clostridium
sporogenes
Lachnoanaerobaculum
saburreum
Peptostreptococcus
stomatis
Clostridium
difficile
Escherichia coli
Rhodobacter
capsulatus
Pseudomonas
stutzeri
Haliangium
ochraceum
Anoxybacillus
flavithermus
Streptomyces
avermitilis
Advenella
kashmirensis
Oligotropha
carboxidovorans
Riemerella
anatipestifer
Fusobacterium
necrophorum
funduliforme Fnf
Desulfosporosinus
youngiae DSM
Peptoniphilus
indolicus ATCC
Desulfosporosinus
meridiei (strain
Acidaminococcus
fermentans
Carboxydothermus
hydrogenoformans
Oscillibacter
valericigenes
Desulfosporosinus orientis
orientis)
Peptostreptococcus
anaerobius CAG: 621
Chloroflexus aggregans
Marivirga tractuosa (strain
Marinithermus
hydrothermalis (strain
Chitinophaga pinensis
Megasphaera elsdenii
Megasphaera elsdenii
Megasphaera elsdenii
Chloroflexus aurantiacus
Ruegeria pomeroyi DSS-3
The enzyme catalyzing conversion of acrylyl-CoA to acrylate may belong to EC 3.1.2- including EC 3.1.2.4. The enzyme catalyzing conversion of acrylyl-CoA to acrylate may be 3-HP-CoA hydrolase or 3-hydroxyisobutyryl-CoA hydrolase. The enzyme catalyzing conversion of acrylyl-CoA to acrylate may have activity of catalyzing conversion of acrylyl-CoA to acrylate higher than activity of catalyzing the reversed reaction. The enzyme catalyzing the conversion of acrylyl-CoA to acrylate may include amino acid sequences having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to at least one amino acid sequence of SEQ ID NOS: 177 to 182. The polynucleotide encoding the enzyme catalyzing conversion of acrylyl-CoA to acrylate may encode amino acid sequences having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91′)/0 or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to at least one amino acid sequence of SEQ ID NOS: 177 to 182. The polynucleotide encoding the enzyme catalyzing conversion of acrylyl-CoA to acrylate may have a sequence identity of about 95% or more to nucleotide sequences of SEQ ID NOS: 405 to 410. The enzyme catalyzing conversion of acrylyl-CoA to acrylate may be at least one selected from enzymes shown in Table 6. The enzymes shown in Table 6 may be E3-type. The term “sequence*” as used in herein denotes SEQ ID NO. of an amino acid/SEQ ID NO. of a nucleotide.
E. coli
Klebsiella oxytoca
Cronobacter
turicensis
Citrobacter freundii
Salmonella enterica
Shigella flexneri
The microorganism may be microorganisms that are genetically engineered so that expression of the three types of enzyme genes (CoA transferase, 3-HP-CoA dehydratase, and enzyme catalyzing conversion of acrylyl-CoA to acrylate) may increase compared to that of cells that are not genetically engineered. When the activities of the three enzymes were already present in the parent cells, expression of the three enzymes may further increased by genetically engineering the microorganism. Also, when the activities of the three enzymes were not present in the parent (e.g., not genetically engineered) cells, genes that encode the three enzymes may be introduced to parent cells by genetic engineering and express or overexpress the genes. The genetically unengineered cells denote a wild microorganism or parent cells, from which the microorganism is derived.
The expression or overexpression of the three enzymes may be achieved by using various methods known to one of ordinary skill in the art. For example, the expression may be increased by increasing the number of gene copies, or by using a control material such as an inducer or a repressor. The number of gene copies may be increased by introduction or amplification of the gene. That is, the increasing of the number of gene copies may be achieved by introducing a vector or an expression cassette including a regulation element and the three enzyme genes that are operably linked to one another into a host cell.
Also, the increase in the activities of the three genes may be caused by modification of an expression regulatory sequence of the gene. The regulatory sequence may be e.g., a promoter sequence or a transcription terminator sequence for the gene expression. The regulatory sequence may be a sequence that encodes a motif which may influence the gene expression. The motif may be, for example, a secondary structure-stabilizing motif, an RNA destabilizing motif, a splice-activating motif, a polyadenylation motif, an adenine-rich sequence, or an endonuclease recognition site.
The microorganism may be selected from the group consisting of bacteria, yeast, and fungi. The microorganism may be selected from the group consisting of Escherichia, Corynebacterium genus, and Brevibacterium genus. The cells may be Corynebacterium genus. The microorganism may be a microorganism selected from the group consisting of E. coli, Corynebacterium glutamicum, Corynebacterium thermoaminogenes, Brevibacterium flavum, and Brevibacterium lactofermentum.
The microorganism may naturally produce the acrylic acid or may be genetically engineered to produce the acrylic acid by using a recombinant method. In this case, the microorganism may be a microorganism capable of producing acrylic acid from monosaccharides such as glucose, or a glycerol. Also, the microorganism may have the capability to produce 3-HP, for example from monosaccharides such as glucose, or a glycerol. The microorganism may have a biochemical pathway forming glycerol from monosaccharides such as glucose. The biochemical pathway may include glycolytic pathway converting monosaccharides such as glucose to dihydroxyacetone phosphate (DHAP), and a pathway converting DHAP to glycerol such as dihydroxyacetone phosphate phosphatase (DHAPP) that catalyzes the conversion of dihydroxyacetone phosphate (DHAP) into dihydroxyacetone (DHA); and glycerol dehydrogenase (GLDH) that catalyzes the conversion of DHA into glycerol. The microorganism may include a polynucleotide encoding dihydroxyacetone phosphate phosphatase (DHAPP) that catalyzes the conversion of dihydroxyacetone phosphate (DHAP) into dihydroxyacetone (DHA); and a polynucleotide encoding glycerol dehydrogenase (GLDH) that catalyzes the conversion of DHA into glycerol. 3-HP produced by the microorganism may be converted to acrylate by the increased CoA transferase activity, 3-HP-CoA dehydratase activity and activity of an enzyme that catalyzes conversion of acrylyl-CoA to acrylate of the claimed microorganism. When the microorganism does not naturally produce 3-HP, the microorganism may be genetically engineered to produce 3-HP. When a gene that encodes an enzyme catalyzing conversion of glycerol to 3-HPA and a gene that encodes an enzyme catalyzing conversion of 3-HPA to 3-HP are introduced to the microorganism, the microorganism may have a 3-HP productivity from glycerol. In this case, the microorganism may be a microorganism capable of producing a glycerol. The microorganism may be, for example, a microorganism of Escherichia genus including E. coli. The enzyme catalyzing conversion of glycerol to 3-HPA may be a glycerol dehydratase (GDH). The enzyme catalyzing conversion of 3-HPA to 3-HP may be an aldehyde dehydrogenase (ALD).
The GDH may include any enzyme catalyzing conversion of glycerol to 3-HPA. The GDH may belong to EC 4.2.1.30 or diol dehydratase (EC 4.2.1.28). The GDH and a nucleotide encoding the GDH may be derived from Ilyobacter polytropus, Klebsiella pneumoniae, Citrobacter freundii, Clostritidium pasteurianum, Salmonella typhimurium, or Klebsiella oxytoca. In each case, the GDH may be composed of three subunits. The subunits may be a large or “α” subunit, a medium or “β” subunit, and a small or “γ” subunit. The gene encoding the large or “α” subunit of the GDH may include dhaB1, gldA, and ghaB. The gene encoding the medium or “β” subunit of the GDH may include dhaB2, gldB, and dhaC. The gene encoding the small or “γ” subunit of the GDH may include dhaB3, gldC, and dhaE. The gene encoding the large or “α” subunit of the diol dehydratase may include pduC and pddA. The gene encoding the medium or “β” subunit of the diol dehydratase may include pduD and pddB. The gene encoding the small or “γ” subunit of the diol dehydratase may include pduE and pddC. Tables 7 and 8 show Gene names and GenBank references with respect to GDH and functions linked to GDH. The GDH may include dhaB1, dhaB2, and dhaB3 that are derived from Ilyobacter polytropus. The Ilyobacter polytropus-derived dhaB1, dhaB2, and dhaB3 may each have amino acid sequences of SEQ ID NOS: 183, 184, and 185, respectively. The dhaB1 gene, dhaB2 gene, and dhaB3 gene may each encode amino acid sequences of SEQ ID NOS: 183, 184, and 185, respectively. The Ilyobacter polytropus-derived dhaB1 gene, dhaB2 gene, and dhaB3 gene may each have nucleotide sequences of SEQ ID NOS: 186, 187, and 188, respectively.
K. pneumoniae (U30903)
K. pneumoniae (U60992)
C. freundii (U09771)
C. pasteurianum (AF051373)
C. pasteurianum (AF026270)
S. typhimurium (AF026270)
K. oxytoca (AF017781)
K. oxytoca (AF051373)
K. pneumoniae (U30903)
K. pneumoniae (U60992)
C. freundii (U09771)
C. pasteurianum (AF051373)
C. pasteurianum (AF026270)
S. typhimurium (AF026270)
K. oxytoca (AF017781)
K. oxytoca (AF051373)
The GDH may include an amino acid sequence having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91′)/0 or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to each sequence of dhaB1, dhaB2, and dhaB3 genes derived from Ilyobacter polytropus.
The ALD may include any protein that may catalyze conversion of 3-HPA to 3-HP. The ALD may use a redox cofactor such as NAD, NADP, FAD, or PQQ. The ALD may be EC 1.2.1.3 (NAD-dependent), EC 1.2.1.4 (NADP-dependent), EC 1.2.99.3 (PQQ-dependent), or EC 1.2.99.7 (FAD-dependent). An example of the NADP-dependent ALD may be AldB, which is encoded by an E. coli gene, aldB. An example of the NAD-dependent ALD may be AldA, which is encoded by an E. coli gene, aldA, or AldH, which is encoded by an E. coli gene, aldH. The ALD may be a succinate semialdehyde dehydrogenase (SSADH). The SSADH may belong to EC 1.2.1.24 or EC 1.2.1.16. The SSADH may be dependent upon NAD+, NADP+, or both. The SSADH may be CoA independent. For example, the SSADH may be derived from Corynebacterium genus, Rhodococcus genus, Gordonia genus, Mycobacterium genus, Enterobacter genus, and Escherichia genus. The SSADH may be gabD1, gabD2, or gabD3 derived from E. coli. For example, a gene encoding the SSADH may be polynucleotides encoding amino acid sequences of SEQ ID NOS: 189, 190, and 191. The SSADH may be gabD (a nucleotide sequence of SEQ ID NO: 192 and an amino acid sequence of SEQ ID NO: 193) derived from Cupriavidus necator. The gene encoding the SSADH may be, for example, a polynucleotide encoding amino acid sequences of SEQ ID NOS: 189, 190, 191, and 193. The gene encoding the SSADH may have, for example, nucleotide sequences of SEQ ID NOS: 194, 195, 196, and 192. The SSADH may include amino acid sequences having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to amino acid sequences of SEQ ID NOS: 189, 190, 191, and 193.
The microorganism may further include a polynucleotide encoding a glycerol dehydratase reactivase (GDR). The glycerol and diol dehydratase may be subject to mechanism-based suicide inactivation by glycerol and other substrates (Daniel et al., FEMS Microbiol. Rev. 22, 553(1999)). The term “glycerol dehydratase reactivase (GDR)” refers to a protein that reactivates activity of the dehydratase. The term “dehydratase reactivating activity” refers to a phenomenon of converting a dehydratase not capable of catalysis of a substrate to one capable of catalysis of a substrate or to the phenomenon of inhibiting the inactivation of a dehydratase or the phenomenon of extending the useful half-life of the dehydratase enzyme in vivo. The GDR may be at least one of dhaB, gdrA, pduG, and ddrA. Also, the GDR may be at least one of orfX, orf2b, gdrB, pduH, and ddrB.
The GDR may be gdrA and gdrB derived from K. pneumoniae (U60992), each of which may have amino acid sequences of SEQ ID NOS: 197 and 198. Also, the GDR may be gdrA and gdrB derived from Ilyobacter polytropus, each of which may have amino acid sequences of SEQ ID NOS: 199 and 200. The GDR may include amino acid sequences having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to amino acid sequences of SEQ ID NOS: 197, 198, 199, and 200. Each of the Genes encoding GdrA and GdrB may have sequences encoding amino acid sequences of SEQ ID NOS: 197, 198, 199, and 200 or, for example, nucleotide sequences of SEQ ID NOS: 201, 202, 203, and 204.
In the microorganism, at least one of the polynucleotide encoding GDH, the polynucleotide encoding ALD, and the polynucleotide encoding GDR may be expressed at a level higher than that of an unengineered or parent microorganism. The expression level may be expression of mRNA or protein level. The expression of protein level may be based on an amount or activity of the expressed protein. The expression level may be about 5% or more, about 10% or more, about 15% or more, about 20% or more, about 30% or more, about 50% or more, about 60% or more, about 70% or more, about 100% or more, 200% or more, or 300% or more increased than that of an unengineered microorganism.
The microorganism may have a 3-HP productivity. In the microorganism, the increase in the expression of at least one of the polynucleotide encoding GDH, the polynucleotide encoding ALD, and the polynucleotide encoding GDR may allow the 3-HP to be produced at a higher level than in an unengineered microorganism. The 3-HP production may be performed by using a method of in-cell production, a method of secretion to outside the cell after producing inside the cell, or a combination thereof. The 3-HP produced inside the cell may be converted from another metabolic product such as an acrylic acid. The 3-HP production may be about 5% or more, about 10% or more, about 15% or more, about 20% or more, about 30% or more, about 50% or more, about 60% or more, about 70% or more, about 100% or more, about 200% or more, or about 300% or more increased than that of an unengineered microorganism.
The increased expression of at least one of the polynucleotide encoding GDH, the polynucleotide encoding ALD, and the polynucleotide encoding GDR may occur by introducing a polynucleotide encoding a polypeptide into a cell, increasing a copy number of the polynucleotide in the cell, or mutating a regulatory region of the polynucleotide. A polynucleotide that is introduced or present in an increased copy number may be an endogenous gene or an exogenous gene. The endogenous gene refers to a gene that exists in a genetic material included in a microorganism. The exogenous gene refers to a gene that is introduced into a host cell, such as a gene that is integrated into a host cell genome, wherein the introduced gene may be homologous or heterologous with respect to the host cell genome.
The microorganism may have reduced activity of one or more enzymes involved in a pathway of decomposition or conversion of an acrylate to another product. In the microorganism, a gene encoding one or more enzymes involved in a pathway of decomposition or conversion of an acrylate to another product may be deleted or disrupted.
Also, the microorganism may further include a pathway of conversion of an acrylate to the other product. In the microorganism, production of an acrylate may be performed by using a method of in-cell production or a method of secretion after producing in the cell. Thus, the microorganism may further include the pathway involved in production of acrylate in a cell and conversion to the other product, for example, an enzyme gene and its expressed product. The other product may be an acrylate ester.
The microorganism may have an inactivated or reduced pathway of synthesizing lactate from pyruvate. In the microorganism, activity of lactate dehydrogenase (LDH) may be deleted or reduced. The LDH may have activity of catalyzing conversion of pyruvate to lactate. The LDH may be an enzyme that is classified under EC.1.1.1.27. For example, the LDH may include amino acid sequences having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to an amino acid sequence of SEQ ID NO: 205. In the microorganism, a gene encoding lactate dehydrogenase may be disrupted or deleted. The LDH gene may encode amino acid sequences having a sequence identity of 65% or more, for example, 70% or more, 80% or more, 85% or more, 90% or more, 91% or more, 92% or more, 93% or more, 94% or more, 95% or more, 96% or more, 97% or more, 98% or more, 99% or more, or 100% to an amino acid sequence of SEQ ID NO: 205.
According to another aspect of the present disclosure, provided is a method of producing acrylate, the method including culturing the microorganism described above in a culture medium.
The culturing of the microorganism may be performed in a suitable medium under suitable culturing conditions known in the art. One of ordinary skill in the art may suitably change a culture medium and culturing conditions according to the microorganism selected. A culturing method may be batch culturing, continuous culturing, fed-batch culturing, or a combination thereof. The microorganism may secrete acrylate to outside the cell.
The culture medium may include various carbon sources, nitrogen sources, and trace elements.
The carbon source may be, for example, carbohydrate such as glucose, sucrose, lactose, fructose, maltose, starch, or cellulose; fat such as soybean oil, sunflower oil, castor oil, or coconut oil; fatty acid such as palmitic acid, stearic acid, linoleic acid; alcohol such as glycerol or ethanol; organic acid such as acetic acid, or a combination thereof. The culturing may be performed by having glucose as the carbon source. The nitrogen source may be an organic nitrogen source such as peptone, yeast extract, beef stock, malt extract, corn steep liquor (CSL), or soybean flour, or an inorganic nitrogen source such as urea, ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate, and ammonium nitrate, or a combination thereof. The culture medium is a supply source of phosphorus and may include, for example, potassium dihydrogen phosphate, dipotassium phosphate, and corresponding sodium-containing salt thereof, and a metal salt such as magnesium sulfate or iron sulfate. Also, amino acid, vitamin, a suitable precursor, or the like may be included in the culture medium. The culture medium or individual component may be added to a culture medium solution in a batch, fed-batch, or continuous manner.
Also, pH of the culture medium solution may not be adjusted or may be adjusted by adding a compound such as ammonium hydroxide, potassium hydroxide, ammonia, phosphoric acid, and sulfuric acid to the culture medium solution by using a suitable method during the culturing process. Also, an antifoaming agent such as fatty acid polyglycol ester may be used during the culturing process to inhibit the generation of bubbles.
The culturing process may be performed in a microaerobic condition. As used herein, the term “microaerobic conditions” when used in reference to a culture or growth condition is intended to mean that the dissolved oxygen concentration in the medium remains between 0 and about 10% of saturation for dissolved oxygen in liquid media. Microaerobic conditions also include growing or resting cells in liquid medium or on solid agar inside a sealed chamber maintained with an atmosphere of less than 1% oxygen. The percent of oxygen can be maintained by, for example, sparging the culture with an N2/CO2 mixture or other suitable non-oxygen gas or gases. The oxygen conditions for the acrylic acid production may include maintaining a dissolved oxygen (DO) concentration of 1 to 10%, 1 to 8%, 1 to 6%, 1 to 4%, or 1 to 2%, 2 to 10%, 2 to 8%, 2 to 6%, 2 to 4%, 3 to 10%, 3 to 8%, 3 to 6%, 4 to 10%, 4 to 8%, or 4 to 6% of saturation for dissolved oxygen in liquid media.
The method may further include recovering acrylate from the culture (e.g., from the culture medium). The collecting may include isolating acrylate from the cells, from the culture solution (i.e. medium) except the cells, or from both the cells and the culture solution. The isolation of acrylate from the culture may be performed by a separation and purification method known in the art. The collecting may be performed by centrifugation, chromatography, extraction, filtration, precipitation, or a combination thereof.
In the method, the microorganism further includes a pathway of converting acrylate to the other product, and thus the method may further include converting the produced acrylate to the other product. The other product may be an acrylate ester including a polyacrylate.
According to an aspect of the present disclosure, a microorganism has an increased productivity of 3-acrylic acid.
According to another aspect of the present disclosure, an acrylic acid may be efficiently produced.
Hereinafter, the present disclosure is described in greater detail with reference to embodiments. However, the embodiments are for illustrative purposes only and do not limit the scope of the present invention.
In this example, each of the enzyme activities of converting 3-HP to 3-HP-CoA, AA-CoA, and AA was confirmed. That is, the activities of an enzyme catalyzing conversion of 3-HP to 3-HP-CoA, an enzyme catalyzing conversion of 3-HP-CoA to AA-CoA, and an enzyme catalyzing conversion of AA-CoA to AA were confirmed in vitro. As a result, enzymes catalyzing the forward reaction to occur more dominantly than the reverse reaction thereof were isolated.
(1) Confirmation of Enzyme Catalyzing Conversion of 3-HP to 3-HP-CoA
First, CoA-transferase genes catalyzing conversion of 3-HP to 3-HP-CoA listed in Table 1 were amplified by PCR using genomic DNAs of microorganisms shown in Table 1 as a template and primer sets each including a HindIII restriction site or a BamHI restriction site. 30 cycles of the PCR were performed 30 seconds at 95° C., 30 seconds at 50° C., and 1 minute at 72° C. Table 9 shows the primers used in the PCR.
The amplified products thus obtained were digested with HindIII and BamHI, and the resultants were connected to HindIII and BamHI sites of a pETDuet™-1 vector (Novagen, cat. no. 71146-3) to prepare a CoA-transferase gene expression vector (hereinafter, also referred to as a pETDuet™-1(CT) vector). Each of the enzymes in the expression vector was operably linked with a His-Tag encoding sequence in the vector so that the expression product was expressed in a His-Tag fused form.
The pETDuet™-1(CT) vector obtained therefrom was transformed and then introduced to Escherichia coli BL21(DE3). The transformed E. coli was inoculated in an LB medium and incubated in a 100 mL flask at 37° C. During the incubation, when optical density at 600 nanometers (OD600) was 0.6 to 0.8, 1 mM IPTG was added to induce the expression of an introduced CoA transferase gene. After 24 hours of expression induction, only cells were separated by performing centrifugation, were put into Solution 1 (50 mM NaH2PO4, 0.5 M NaCl, and pH7.4) with ice, and then sonicated to disrupt the cells. Then, the protein was separated using a Ni Sepharose™ High Performance HIS Trap™ HP (GE Healthcare Bio-Sciences AB) kit. Briefly, after cell disruption, only the supernatant was separated from the cell debris by performing centrifugation, the supernatant was mixed with Ni Sepharose resin to bind the protein to the resin, the resin was washed with the solution 1, and then, after packing the resin in chromatography column, the protein was eluted from the resin using 200 mM of imidazole as elution buffer as indicated by the manufacturer to obtain an enzyme solution including each of the enzymes at a high purity in a 200 mL imidazole aqueous solution.
Activity of each CoA-transferase was analyzed as follows: In particular, after adding 100 mM Tris-HCl (pH 8.4), 2 mM MgCl2, 3 mM ATP, and 15 mM CoA-containing aqueous solution, the enzyme solution (at an amount equivalent to 10 mg CoA transferase), and 10 mM 3-HP as a medium were mixed and reacted for about 2 minutes to about 10 minutes. The expected reaction scheme was as follows:
3-HP+acetyl-CoA+ATP+CoA transferase->3-HP-CoA+acetate+CoA transferase
Next, each of the reactants from the reaction was analyzed to confirm peaks and the amounts of the reactant, acetyl-CoA, and the product, 3-HP-CoA, by performing an HPLC analysis. The HPLC analysis was performed by using an Aminex HPX-87H (300 mm×7.8 mm) column and 0.5 mM of a sulfuric acid solution containing 9% of acetonitrile as a mobile phase. A flow rate was 0.4 ml/min, a temperature of the column was 35° C., and the RI detector and UV/VIS (210 nm) dual-mode were used.
Also, each of the reactants from the reaction was reacted with a citrate synthase to convert the remaining acetyl-CoA to CoA, 0.5 mM of DTNB (5,5′-Dithiobis-(2-Nitrobenzoic Acid) or an Ellman's reagent) was added thereto, and then an absorbance was measured at 412 nm. DTNB may be used to measure the amount of thiol in a material by measuring the absorbance thereof. DTNB easily forms a disulfide mixed by thiol and releases chromophore 5-merapto-2-nitrobenzoic acid (having a maximum absorbance at 410 nm). Only thiol among materials that may approach this water-soluble sample may be modified. As a result, activity of each of the enzymes was confirmed by comparing the amount of the remaining acetyl-CoA with its initial amount.
Table 10 shows the amounts of consumed acetyl-CoA, compared with their initial amounts.
As shown in Table 10, when the amount of acetyl-CoA decreased, it was considered that the amount of 3-HP-CoA increased, and, as a result, it was confirmed that 10 of the enzymes catalyzed the conversion of 3-HP to 3-HP-CoA.
(2) Confirmation of Enzyme Catalyzing Conversion of 3-HP-CoA to AA-CoA
First, the dehydratase genes listed in Tables 2 to 5 that catalyze conversion of 3-HP-CoA to AA-CoA were amplified by PCR using genomic DNAs of microorganisms shown in Tables 2 to 5 as a template and primer sets each including a HindIII restriction site or a BamHI restriction site. Then, a dehydratase enzyme was produced and purified in the same manner as in the process (1), except that a pACYCDuet™-1 vector (Novagen, cat. no. 71147-3) was used instead of a pETDuet™-1 vector (Novagen, cat. no. 71146-3). Table 11 shows information about the primer sets used in the PCR. In Table 11, numbers denote serial numbers of the enzymes or the genes in Tables 2 to 5.
Activity of each of the purified dehydratases was analyzed as follows: For example, in the reaction that is catalyzed by a dehydratase such as a 3-HP-CoA/lactoyl-CoA dehydratase, an acrylyl-CoA reductase was added to the reactant to produce propionyl-CoA, and then the amount of consumed NAD(P)H was measured instead of directly measuring the amount of the reactant or the product of the reaction. In particular, 0.05 to 0.2 units of CoA transferase (which is derived from E. coli shown in No. 2 in Table 1) was added to 100 mM of MOPS (3-(N-morpholino)propanesulfonic acid)-KOH (pH 7.0), 10 mM MgCl2, 3 mM ATP, 0.1 mM CoA, and 0.5 ml of 20 mM 3-HP-containing aqueous solution, and the mixture was pre-incubated for about 3 minutes. Then, each of the purified dehydratases (10 mM) was added to the pre-incubated mixture and then allowed to react for about 5 minutes at a temperature of 35° C. The expected reaction scheme was as follows:
3-HP+acetyl-CoA+ATP+CoA transferase->3-HP-CoA+acetate+dehydratase->AA-CoA+NAD(P)H+Acrylyl-CoA reductase (YhdH)->propionyl-CoA+NAD(P)
Next, as the result of the reaction, a decrease in the amount of NAD(P)H according to the addition of 5 mM NAD(P)H/AcuI was confirmed. AcuI is an acrylyl-CoA reductase which was added with a YhdH resemblant. The final NAD(P)H measurement was performed by measuring an absorbance at 340 nm.
Table 12 shows the remaining amounts of NAD(P)H, compared to their initial amounts (i.e., a degree of enzyme activity), as the results of the analysis.
As shown in Table 12, it was confirmed that 79 of the enzymes catalyzed the conversion of 3-HP-CoA to AA-CoA.
Next, with respect to each of the reactants from the reaction, peaks and amounts of the reactant and the product were confirmed in the same manner as in the process (1). As the result of the HPLC analysis, it was confirmed that 79 of the enzymes listed in Tables 2 to 5 produced AA-CoA and thus were confirmed as having activity of catalyzing conversion of 3-HP-CoA to AA-CoA.
(3) Confirmation of Enzyme Catalyzing Conversion of AA-CoA to AA
First, a vector was prepared in the same manner as in the process (1), the vector was introduced to E. coli, and an enzyme was produced and purified, except that the CoA hydrolase genes catalyzing conversion of AA-CoA to AA, the genes listed in Table 6, were amplified by PCR using genomic DNAs of microorganisms shown in Table 6 as a template and primer sets each including a HindIII restriction site or a BamHI restriction site. Then, Table 13 shows information about the primer sets used in the PCR. In Table 13, numbers denote serial numbers of the enzymes or the genes in Table 6.
Activity of each of the purified CoA hydrolases was analyzed as follows: In particular, 100 mM Tris-HCl (pH 8.4), 2 mM MgCl2, 3 mM ATP, 15 mM AA-CoA-containing aqueous solution and the enzyme solution (at an amount equivalent to 10 mg CoA hydrolase) were mixed and reacted for about 2 minutes to about 10 minutes. The expected reaction scheme was as follows:
AA-CoA+CoA hydrolase->AA+free CoA
Next, with respect to each of the reactants from the reaction, peaks and amounts of the reactant and the product (e.g., AA) were confirmed in the same manner as in the process (1) by performing an HPLC analysis. As a result of the HPLC analysis, it was confirmed that 6 of the enzymes listed in Table 6 produced the final product AA.
Also, with respect to each of the reactants from the reaction, the amount of the free CoA was confirmed by measuring an absorbance at 410 nm in the same manner as in the process (1). As the result, it was confirmed that 6 of the enzymes in Table 6 had activity of catalyzing the conversion of AA-CoA to AA. Table 14 shows the measurement results of the produced free CoA.
As shown in Table 14, it was confirmed that 6 of the enzymes listed in Table 6 had activity of catalyzing the conversion of AA-CoA to AA.
In this example, E. coli-derived CoA transferase (ydiF) genes, M. elsdenii-derived dehydratase MELS—1449 genes, and E. coli-derived CoA hydrolase yciA genes, which were confirmed as having the highest activity among CoA transferase genes, dehydratase genes, and CoA hydrolase genes in Example 1, were introduced to E. coli having 3-HP productivity, and the production of AA in the E. coli was confirmed.
(1) Preparation of E. coli Having 3-HP Productivity
(1.1) Manufacture of ET_BAB_Dc5 Vector
In order to prepare a microorganism producing 3-hydroxypropionic acid from glycerol, an ET_BAB_Dc5 vector was manufactured.
Genes (dhaB1, dhaB2, and dhaB3)(SEQ ID NOS: 186, 187, and 188) encoding a glycerol dehydratase (GDH) from a genomic DNA of Ilyobacter polytropus and genes (gdrA and gdrB)(SEQ ID NOS: 201 and 202) encoding a glycerol dehydratase reactivase (GDR) were secured. As an amplification product, dhaB123 was obtained by performing PCR amplification on the dhaB1, dhaB2, and dhaB3 genes using genomic DNAs of Ilyobacter polytropus as a template and primer sets of dhaB123_F (SEQ ID NO: 394) and dhaB123_R (SEQ ID NO: 395). As an amplification product, gdrAB was obtained by performing PCR amplification on the gdrA and gdrB genes using genomic DNA of Ilyobacter polytropus as a template and primer sets of gdrAB_F (SEQ ID NO: 396) and gdrAB_R (SEQ ID NO: 397). The PCR products thus obtained were treated with BamHI and SacI restrictive enzymes and then cloned to a pETDuet™-1 vector (Novagen).
Also, a gene (gabD, SEQ ID NO: 398) encoding a succinate semialdehyde dehydrogenase (SSADH) was obtained by PCR amplification using a genomic DNA of Cupriavidus necator as a template and primer sets of gabD_F (SEQ ID NO: 399) and gabD_R (SEQ ID NO: 400). The PCR product thus obtained was treated with NdeI and KpnI restrictive enzymes and cloned to the vector. As the result, a pETDuet-1/dhaB_gdrAB_gabD4 vector was obtained.
(1.2) Evaluation of 3-HP Productivity
A vector, pETDuet/dhaB_gdrAB_gabD4, produced in the process (1) was transformed and then introduced to Escherichia coli K(DE3).
The culture was performed by culturing the cells in a 50 ml culture medium (including (1.4 g/L of MgSO4H2O, 17.4 g/L of K2HPO4, 3 g/L of KH2PO4, 4 g/L of (NH4)2HPO4, 1.7 g/L of citric acid, 0.014 g/L of ZnCl2, 0.041 g/L of FeCl2H2O, 0.015 g/L of MnCl2, 0.0015 g/L of CuCl2, 0.003 g/L of H3BO3, 0.0025 g/L of Na2MoO4, 200 mg/L of nitriloacetic acid, 30 μg/L of sodium selenate, and 40 g/L of glycerol) in a 250 ml flask at a temperature of 33° C. and at a rate of 250 rpm. Initially, when an absorbance (OD) at 600 nm was 0.8, expression was induced by using 0.05 mM of IPTG, and then 50 μM of vitamin B12 was added.
After culturing for 24 hours, a part of the culture solution was extracted, an absorbance and pH of the culture solution were measured, and then production of 3-HP was confirmed by using an HPLC (Waters). The pH was adjusted to pH 7.0 by using 4 N of NaOH every 24 hours. The HPLC analysis was performed by using an Aminex HPX-87H (300 mm×7.8 mm) column and 0.5 mM of a sulfuric acid solution containing 9% of acetonitrile as a mobile phase. A flow rate was 0.4 ml/min, a temperature of the column was 35° C., and the RI detector and UV/VIS (210 nm) dual-mode were used. The 3-HP was detected at 17.5 minutes during the total analysis time of 30 minutes.
As a result, a strain obtained by transforming a vector, pETDuet/dhaB_gdrAB_gabD4, to E. coli K(DE3) was cultured in a 100 ml flask for 24 hours under the same conditions described above, and an amount of the 3-HP product was 13.2 g/L.
(2) Preparation of AA Production Strain
First, in the same manner as in the process (1), (2), and (3) of Example 1, ydiF gene, MELS—1449 gene, and yciA gene were amplified, and each of the genes were digested by using a restriction enzyme. Then, the genes were sequentially connected to a pETDuet™-1 vector, which was digested by the same enzyme, and a vector (pETDuet™-1/MELS—1449_yciA_YdiF) for expressing the three genes was prepared. Here, primers (SEQ ID NOS: 208/209, 236/237, and 382/383) used in amplification of ydiF gene, MELS—1449 gene, and yciA gene have restriction sites BamHI and HindIII, NdeI and BglII, and BglII and XhoI, respectively. When connected to the vector, the genes were digested by using the enzymes. In the vector for expression, each of the enzymes was operably linked with a His-Tag encoding sequence in the vector, and thus the expression product was expressed in the form that is fused with a His-tag.
Next, the pETDuet™-1/MELS—1449_yciA_YdiF vector was transformed to E. coli K(DE3) (pETDuet_dhaB_gdrAB_gabD4), which was a strain having 3-HP productivity. E. coli, to which the pETDuet™-1/MELS—1449_yciA_YdiF thus obtained was introduced, was inoculated into 100 mL of a M9 minimum culture medium (including 1.4 g/L of MgSO4H2O, 17.4 g/L of K2HPO4, 3 g/L of KH2PO4, 4 g/L of (NH4)2HPO4, 1.7 g/L of citric acid, 0.014 g/L of ZnCl2, 0.041 g/L of FeCl2H2O, 0.015 g/L of MnCl2, 0.0015 g/L of CuCl2, 0.003 g/L of H3BO3, 0.0025 g/L of Na2MoO4, 200 mg/L of nitriloacetic acid, 30 μg/L of sodium selenate, and 40 g/L of glycerol) so that OD600 was 0.1 and cultured at a temperature of 30° C. until OD600 was 0.6. Then, 0.02 mM of IPTG was added thereto and cultured at temperature of 33° C. for 24 hours. The culture was performed by shake culturing in a 250 mL flask for 24 hours.
Then, the expressed MELS—1449, YdiF, and YciA were separated and purified in the same manner as in the process (1), (2), and (3) of Example 1, an in vitro enzyme reaction was performed on a combination of the three purified enzymes, and the reaction product was analyzed by using a mass spectrometry. As a result, 0.5 g/L of AA was produced.
Thereafter, a concentration of acrylic acid in the culture was measured by using an HPLC. In particular, when the culture was terminated, a part of the culture solution was obtained to measure an absorbance, and then AA production in the culture without cells was confirmed by using HPLC (Waters). The HPLC analysis was performed by using an Aminex HPX-87H (300 mm×7.8 mm) column and 0.5 mM of a sulfuric acid solution containing 9% of acetonitrile as a mobile phase. A flow rate was 0.4 ml/min, a temperature of the column was 35° C., and the RI detector and UV/VIS (210 nm) dual-mode were used. As the result of the HPLC analysis, it was confirmed that the recombinant E. coli strain produced 0.50 g/L of acrylic acid (AA) after 24 hours of culture.
It should be understood that the exemplary embodiments described therein should be considered in a descriptive sense only and not for purposes of limitation. Descriptions of features or aspects within each embodiment should typically be considered as available for other similar features or aspects in other embodiments.
While one or more embodiments of the present disclosure have been described with reference to the figures, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present invention as defined by the following claims.
All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
The use of the terms “a” and “an” and “the” and “at least one” and similar referents in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. The use of the term “at least one” followed by a list of one or more items (for example, “at least one of A and B”) is to be construed to mean one item selected from the listed items (A or B) or any combination of two or more of the listed items (A and B), unless otherwise indicated herein or clearly contradicted by context. The terms “comprising,” “having,” “including,” and “containing” are to be construed as open-ended terms (i.e., meaning “including, but not limited to,”) unless otherwise noted. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
Preferred embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred embodiments may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10-2014-0057954 | May 2014 | KR | national |
